Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CoAptus Medical Corp.

www.coaptus.com

Latest From Benitec Biopharma Ltd.

Biopharma Quarterly Dealmaking Statistics, Q3 2015

Biopharma financing totaled $9.7 billion, almost half from follow-on public offerings; there was big consolidation in the generics and health services industries. AstraZeneca signed a dozen partnerships, many of which focused on oncology.

BioPharmaceutical Deals

Despite Headwinds US IPOs Show Few Signs Of Slowing In Q3

Fifteen drug development firms raised $1.4bn via initial public offerings in the US during the third quarter, which is equal to the quarterly average during the first half of the year and shows that despite recent biotechnology stock headwinds IPOs have not slowed – at least, not yet.

Cancer Neurology

Deals Shaping The Medical Industry, September 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2015.

BioPharmaceutical Medical Device

FINANCE ROUNDUP: An IPO in a tough stock market, two VC deals

Benitec Pharma's painfully small initial public offering during the week of Aug. 17 to 21 was emblematic of recent pain felt within the broader US stock market, but private investors kept to their commitments to fund early-stage and pre-commercial biotechnology venture capital rounds.

Metabolic Disorders Dermatology
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • CoAptus Medical Corp.
  • Senior Management
  • Joseph E Eichinger, Pres.
  • Contact Info
  • CoAptus Medical Corp.
    14963 NE 95th St.
    Redmond, WA 98052
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register